Desenvolvimento e Teste Piloto de uma Estratégia de Implementação para uma Intervenção de Aconselhamento Breve sobre Segurança de Meios Letais Baseada em Entrevista Motivacional em Contextos de Cuidados de Saúde Primários (CDA-2)
Desenvolvimento e Pilotagem de uma Estratégia de Implementação para uma Intervenção Breve de Aconselhamento sobre Segurança de Meios Letais Baseada na Entrevista Motivacional em Contextos de Cuidados de Saúde Primários
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Steve Martino, PhD
- Número de telefone: 2468 (203) 932-5711
- E-mail: Steve.Martino@va.gov
Estude backup de contato
- Nome: Frances Aunon, PhD MS
- Número de telefone: 7894 (203) 932-5711
- E-mail: Frances.Aunon@va.gov
Locais de estudo
-
-
Connecticut
-
West Haven, Connecticut, Estados Unidos, 06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contato:
- Steve Martino, PhD
- Número de telefone: 2468 (203) 932-5711
- E-mail: Steve.Martino@va.gov
-
Contato:
- Kimberly L Selander, MA
- Número de telefone: (203) 932-5711
- E-mail: Kimberly.Selander@va.gov
-
Investigador principal:
- Frances Aunon, PhD MS
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
For Veterans:
- Has access to a firearm
- Referred to Primary Care Mental Health Integration (PCMHI) care
For clinicians (delivering intervention):
- Deliver care in Primary Care Mental Health Integration (PCMHI)
- Trained in RAMP and study procedures
Exclusion Criteria:
For Veterans:
- Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
- Unreliable telephone access
- Inability to read English or communicate in spoken and written English
For clinicians (delivering intervention):
- Did not participate in training
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Comparador Ativo: Active control
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
|
Experimental: RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Screening
Prazo: through study completion, approximately 2 years
|
Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month |
through study completion, approximately 2 years
|
|
Recruitment
Prazo: through study completion, approximately 2 years
|
Investigators will track the number of eligible Veterans who enrolled in the study per month |
through study completion, approximately 2 years
|
|
Retention
Prazo: approximately 30 days
|
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments. |
approximately 30 days
|
|
Assessment of behavioral outcomes
Prazo: approximately 30 days
|
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint |
approximately 30 days
|
|
Veteran acceptability - Theoretical Framework of Acceptability
Prazo: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Veteran acceptability - Experience and Satisfaction with intervention
Prazo: At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Clinician acceptability - Theoretical Framework of Acceptability
Prazo: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
|
Clinician acceptability - Negative impact
Prazo: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding >3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration). |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Frances Aunon, PhD MS, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- HSR4-001-24W
- 1IK2RD000503-01A2 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .